About Prismic Pharmaceuticals
Prismic Pharmaceuticals is a company based in Worcester (United States) founded in 2011 was acquired by FSD Pharma in April 2019.. Prismic Pharmaceuticals has raised $1.2 million across 1 funding round from investors including FSD Pharma. Prismic Pharmaceuticals offers products and services including Motor Reviews, Buying-Selling Platform, and Motor Information Service.
- Headquarter Worcester, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.2 M (USD)
in 1 rounds
-
Latest Funding Round
$1.2 M (USD), Seed
Feb 20, 2013
- Investors
-
Employee Count
Employee Count
-
Acquired by
FSD Pharma
(Apr 23, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prismic Pharmaceuticals
Prismic Pharmaceuticals offers a comprehensive portfolio of products and services, including Motor Reviews, Buying-Selling Platform, and Motor Information Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides detailed reviews and information on popular motor models.
Facilitates online buying and selling of motor-related items.
Offers data on specific motors like Motor 1 and Motor 2.
Funding Insights of Prismic Pharmaceuticals
Prismic Pharmaceuticals has successfully raised a total of $1.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.2 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.2M
-
First Round
First Round
(20 Feb 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2013 | Amount | Seed - Prismic Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prismic Pharmaceuticals
Prismic Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prismic Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prismic Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prismic Pharmaceuticals Comparisons
Competitors of Prismic Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Prismic Pharmaceuticals
When was Prismic Pharmaceuticals founded?
Prismic Pharmaceuticals was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Prismic Pharmaceuticals located?
Prismic Pharmaceuticals is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
Is Prismic Pharmaceuticals a funded company?
Prismic Pharmaceuticals is a funded company, having raised a total of $1.2M across 1 funding round to date. The company's 1st funding round was a Seed of $1.2M, raised on Feb 20, 2013.
What does Prismic Pharmaceuticals do?
Prismic Pharmaceuticals is a development-stage specialty pharmaceutical company, which focuses on the research and development of patent protected products to address inflammation and oxidative stress associated with renal and mental health disorders. Currently has two pharmaceutically active ingredients, ultra-micronized palmitoylethanolamide, and ultra-pure EPA-based Omega-3, in development to address disorders associated with kidney disease, mental health, and chronic pain. Plan to develop proprietary products in two distinct FDA categories, prescription Medical Foods and Prescription Drugs. Medical food pipeline includes Neurepa, Nefrogesic, Nefrosil and Neurepa Le. Prescription Drugs pipeline includes ultra-micronized palmitoylethanolamide (UM PEA) Morphine, UM PEA Pregabalin, UM PEA Hydrocodone, UM PEA Oxycodone, UM PEA and UM PEA Silymarin.
What products or services does Prismic Pharmaceuticals offer?
Prismic Pharmaceuticals offers Motor Reviews, Buying-Selling Platform, and Motor Information Service.
Who are Prismic Pharmaceuticals's investors?
Prismic Pharmaceuticals has 1 investor. Key investors include FSD Pharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.